Medical Care

Global Nano-based Drug Delivery System Market Research Report 2025

The global market for Nano-based Drug Delivery System was valued at US$ 4780 million in the year 2024 and is projected to reach a revised size of US$ 5668 million by 2031, growing at a CAGR of 2.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nano-based Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nano-based Drug Delivery System.
The Nano-based Drug Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nano-based Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nano-based Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Segment by Type
Less than 50nm
50-150nm
150-300nm
Others
Segment by Application
Hydrophilic Drugs
Hydrophobic Drugs
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nano-based Drug Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nano-based Drug Delivery System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Less than 50nm
1.2.3 50-150nm
1.2.4 150-300nm
1.2.5 Others
1.3 Market by Application
1.3.1 Global Nano-based Drug Delivery System Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hydrophilic Drugs
1.3.3 Hydrophobic Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nano-based Drug Delivery System Market Perspective (2020-2031)
2.2 Global Nano-based Drug Delivery System Growth Trends by Region
2.2.1 Global Nano-based Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nano-based Drug Delivery System Historic Market Size by Region (2020-2025)
2.2.3 Nano-based Drug Delivery System Forecasted Market Size by Region (2026-2031)
2.3 Nano-based Drug Delivery System Market Dynamics
2.3.1 Nano-based Drug Delivery System Industry Trends
2.3.2 Nano-based Drug Delivery System Market Drivers
2.3.3 Nano-based Drug Delivery System Market Challenges
2.3.4 Nano-based Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nano-based Drug Delivery System Players by Revenue
3.1.1 Global Top Nano-based Drug Delivery System Players by Revenue (2020-2025)
3.1.2 Global Nano-based Drug Delivery System Revenue Market Share by Players (2020-2025)
3.2 Global Nano-based Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nano-based Drug Delivery System Revenue
3.4 Global Nano-based Drug Delivery System Market Concentration Ratio
3.4.1 Global Nano-based Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nano-based Drug Delivery System Revenue in 2024
3.5 Global Key Players of Nano-based Drug Delivery System Head office and Area Served
3.6 Global Key Players of Nano-based Drug Delivery System, Product and Application
3.7 Global Key Players of Nano-based Drug Delivery System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nano-based Drug Delivery System Breakdown Data by Type
4.1 Global Nano-based Drug Delivery System Historic Market Size by Type (2020-2025)
4.2 Global Nano-based Drug Delivery System Forecasted Market Size by Type (2026-2031)
5 Nano-based Drug Delivery System Breakdown Data by Application
5.1 Global Nano-based Drug Delivery System Historic Market Size by Application (2020-2025)
5.2 Global Nano-based Drug Delivery System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nano-based Drug Delivery System Market Size (2020-2031)
6.2 North America Nano-based Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nano-based Drug Delivery System Market Size by Country (2020-2025)
6.4 North America Nano-based Drug Delivery System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nano-based Drug Delivery System Market Size (2020-2031)
7.2 Europe Nano-based Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nano-based Drug Delivery System Market Size by Country (2020-2025)
7.4 Europe Nano-based Drug Delivery System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nano-based Drug Delivery System Market Size (2020-2031)
8.2 Asia-Pacific Nano-based Drug Delivery System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2020-2025)
8.4 Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nano-based Drug Delivery System Market Size (2020-2031)
9.2 Latin America Nano-based Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nano-based Drug Delivery System Market Size by Country (2020-2025)
9.4 Latin America Nano-based Drug Delivery System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nano-based Drug Delivery System Market Size (2020-2031)
10.2 Middle East & Africa Nano-based Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2020-2025)
10.4 Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Nano-based Drug Delivery System Introduction
11.1.4 Amgen Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.1.5 Amgen Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Nano-based Drug Delivery System Introduction
11.2.4 Teva Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.2.5 Teva Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Nano-based Drug Delivery System Introduction
11.3.4 Roche Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.3.5 Roche Recent Development
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Details
11.4.2 UCB (Union Chimique Belge) Business Overview
11.4.3 UCB (Union Chimique Belge) Nano-based Drug Delivery System Introduction
11.4.4 UCB (Union Chimique Belge) Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.4.5 UCB (Union Chimique Belge) Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Nano-based Drug Delivery System Introduction
11.5.4 Celgene Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.5.5 Celgene Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Nano-based Drug Delivery System Introduction
11.6.4 Merck Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.6.5 Merck Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Details
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Nano-based Drug Delivery System Introduction
11.7.4 Gilead Sciences Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.7.5 Gilead Sciences Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Nano-based Drug Delivery System Introduction
11.8.4 Sanofi Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.8.5 Sanofi Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nano-based Drug Delivery System Introduction
11.9.4 Pfizer Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Nano-based Drug Delivery System Introduction
11.10.4 Takeda Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.10.5 Takeda Recent Development
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Details
11.11.2 Bausch&Lomb Business Overview
11.11.3 Bausch&Lomb Nano-based Drug Delivery System Introduction
11.11.4 Bausch&Lomb Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.11.5 Bausch&Lomb Recent Development
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Details
11.12.2 Samyang Biopharmaceuticals Business Overview
11.12.3 Samyang Biopharmaceuticals Nano-based Drug Delivery System Introduction
11.12.4 Samyang Biopharmaceuticals Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.12.5 Samyang Biopharmaceuticals Recent Development
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Details
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Nano-based Drug Delivery System Introduction
11.13.4 Johnson & Johnson Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.13.5 Johnson & Johnson Recent Development
11.14 TOLMAR
11.14.1 TOLMAR Company Details
11.14.2 TOLMAR Business Overview
11.14.3 TOLMAR Nano-based Drug Delivery System Introduction
11.14.4 TOLMAR Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.14.5 TOLMAR Recent Development
11.15 Astellas
11.15.1 Astellas Company Details
11.15.2 Astellas Business Overview
11.15.3 Astellas Nano-based Drug Delivery System Introduction
11.15.4 Astellas Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.15.5 Astellas Recent Development
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Details
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Nano-based Drug Delivery System Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.16.5 AMAG Pharmaceuticals Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Details
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Nano-based Drug Delivery System Introduction
11.17.4 AbbVie Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.17.5 AbbVie Recent Development
11.18 Dr Reddy
11.18.1 Dr Reddy Company Details
11.18.2 Dr Reddy Business Overview
11.18.3 Dr Reddy Nano-based Drug Delivery System Introduction
11.18.4 Dr Reddy Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.18.5 Dr Reddy Recent Development
11.19 AstraZeneca
11.19.1 AstraZeneca Company Details
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Nano-based Drug Delivery System Introduction
11.19.4 AstraZeneca Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.19.5 AstraZeneca Recent Development
11.20 Aspen
11.20.1 Aspen Company Details
11.20.2 Aspen Business Overview
11.20.3 Aspen Nano-based Drug Delivery System Introduction
11.20.4 Aspen Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.20.5 Aspen Recent Development
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Details
11.21.2 Acrotech Biopharma Business Overview
11.21.3 Acrotech Biopharma Nano-based Drug Delivery System Introduction
11.21.4 Acrotech Biopharma Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.21.5 Acrotech Biopharma Recent Development
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Details
11.22.2 TWi Pharmaceuticals Business Overview
11.22.3 TWi Pharmaceuticals Nano-based Drug Delivery System Introduction
11.22.4 TWi Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2020-2025)
11.22.5 TWi Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nano-based Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Less than 50nm
Table 3. Key Players of 50-150nm
Table 4. Key Players of 150-300nm
Table 5. Key Players of Others
Table 6. Global Nano-based Drug Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Nano-based Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nano-based Drug Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Nano-based Drug Delivery System Market Share by Region (2020-2025)
Table 10. Global Nano-based Drug Delivery System Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Nano-based Drug Delivery System Market Share by Region (2026-2031)
Table 12. Nano-based Drug Delivery System Market Trends
Table 13. Nano-based Drug Delivery System Market Drivers
Table 14. Nano-based Drug Delivery System Market Challenges
Table 15. Nano-based Drug Delivery System Market Restraints
Table 16. Global Nano-based Drug Delivery System Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Nano-based Drug Delivery System Market Share by Players (2020-2025)
Table 18. Global Top Nano-based Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano-based Drug Delivery System as of 2024)
Table 19. Ranking of Global Top Nano-based Drug Delivery System Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Nano-based Drug Delivery System Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Nano-based Drug Delivery System, Headquarters and Area Served
Table 22. Global Key Players of Nano-based Drug Delivery System, Product and Application
Table 23. Global Key Players of Nano-based Drug Delivery System, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nano-based Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Nano-based Drug Delivery System Revenue Market Share by Type (2020-2025)
Table 27. Global Nano-based Drug Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Nano-based Drug Delivery System Revenue Market Share by Type (2026-2031)
Table 29. Global Nano-based Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Nano-based Drug Delivery System Revenue Market Share by Application (2020-2025)
Table 31. Global Nano-based Drug Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Nano-based Drug Delivery System Revenue Market Share by Application (2026-2031)
Table 33. North America Nano-based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Nano-based Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Nano-based Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Nano-based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Nano-based Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Nano-based Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Nano-based Drug Delivery System Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Nano-based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Nano-based Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nano-based Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Nano-based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 48. Amgen Company Details
Table 49. Amgen Business Overview
Table 50. Amgen Nano-based Drug Delivery System Product
Table 51. Amgen Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 52. Amgen Recent Development
Table 53. Teva Company Details
Table 54. Teva Business Overview
Table 55. Teva Nano-based Drug Delivery System Product
Table 56. Teva Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 57. Teva Recent Development
Table 58. Roche Company Details
Table 59. Roche Business Overview
Table 60. Roche Nano-based Drug Delivery System Product
Table 61. Roche Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 62. Roche Recent Development
Table 63. UCB (Union Chimique Belge) Company Details
Table 64. UCB (Union Chimique Belge) Business Overview
Table 65. UCB (Union Chimique Belge) Nano-based Drug Delivery System Product
Table 66. UCB (Union Chimique Belge) Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 67. UCB (Union Chimique Belge) Recent Development
Table 68. Celgene Company Details
Table 69. Celgene Business Overview
Table 70. Celgene Nano-based Drug Delivery System Product
Table 71. Celgene Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 72. Celgene Recent Development
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Nano-based Drug Delivery System Product
Table 76. Merck Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 77. Merck Recent Development
Table 78. Gilead Sciences Company Details
Table 79. Gilead Sciences Business Overview
Table 80. Gilead Sciences Nano-based Drug Delivery System Product
Table 81. Gilead Sciences Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 82. Gilead Sciences Recent Development
Table 83. Sanofi Company Details
Table 84. Sanofi Business Overview
Table 85. Sanofi Nano-based Drug Delivery System Product
Table 86. Sanofi Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Nano-based Drug Delivery System Product
Table 91. Pfizer Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Takeda Company Details
Table 94. Takeda Business Overview
Table 95. Takeda Nano-based Drug Delivery System Product
Table 96. Takeda Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 97. Takeda Recent Development
Table 98. Bausch&Lomb Company Details
Table 99. Bausch&Lomb Business Overview
Table 100. Bausch&Lomb Nano-based Drug Delivery System Product
Table 101. Bausch&Lomb Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 102. Bausch&Lomb Recent Development
Table 103. Samyang Biopharmaceuticals Company Details
Table 104. Samyang Biopharmaceuticals Business Overview
Table 105. Samyang Biopharmaceuticals Nano-based Drug Delivery System Product
Table 106. Samyang Biopharmaceuticals Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 107. Samyang Biopharmaceuticals Recent Development
Table 108. Johnson & Johnson Company Details
Table 109. Johnson & Johnson Business Overview
Table 110. Johnson & Johnson Nano-based Drug Delivery System Product
Table 111. Johnson & Johnson Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 112. Johnson & Johnson Recent Development
Table 113. TOLMAR Company Details
Table 114. TOLMAR Business Overview
Table 115. TOLMAR Nano-based Drug Delivery System Product
Table 116. TOLMAR Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 117. TOLMAR Recent Development
Table 118. Astellas Company Details
Table 119. Astellas Business Overview
Table 120. Astellas Nano-based Drug Delivery System Product
Table 121. Astellas Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 122. Astellas Recent Development
Table 123. AMAG Pharmaceuticals Company Details
Table 124. AMAG Pharmaceuticals Business Overview
Table 125. AMAG Pharmaceuticals Nano-based Drug Delivery System Product
Table 126. AMAG Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 127. AMAG Pharmaceuticals Recent Development
Table 128. AbbVie Company Details
Table 129. AbbVie Business Overview
Table 130. AbbVie Nano-based Drug Delivery System Product
Table 131. AbbVie Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 132. AbbVie Recent Development
Table 133. Dr Reddy Company Details
Table 134. Dr Reddy Business Overview
Table 135. Dr Reddy Nano-based Drug Delivery System Product
Table 136. Dr Reddy Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 137. Dr Reddy Recent Development
Table 138. AstraZeneca Company Details
Table 139. AstraZeneca Business Overview
Table 140. AstraZeneca Nano-based Drug Delivery System Product
Table 141. AstraZeneca Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 142. AstraZeneca Recent Development
Table 143. Aspen Company Details
Table 144. Aspen Business Overview
Table 145. Aspen Nano-based Drug Delivery System Product
Table 146. Aspen Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 147. Aspen Recent Development
Table 148. Acrotech Biopharma Company Details
Table 149. Acrotech Biopharma Business Overview
Table 150. Acrotech Biopharma Nano-based Drug Delivery System Product
Table 151. Acrotech Biopharma Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 152. Acrotech Biopharma Recent Development
Table 153. TWi Pharmaceuticals Company Details
Table 154. TWi Pharmaceuticals Business Overview
Table 155. TWi Pharmaceuticals Nano-based Drug Delivery System Product
Table 156. TWi Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2020-2025) & (US$ Million)
Table 157. TWi Pharmaceuticals Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report


List of Figures
Figure 1. Nano-based Drug Delivery System Picture
Figure 2. Global Nano-based Drug Delivery System Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nano-based Drug Delivery System Market Share by Type: 2024 VS 2031
Figure 4. Less than 50nm Features
Figure 5. 50-150nm Features
Figure 6. 150-300nm Features
Figure 7. Others Features
Figure 8. Global Nano-based Drug Delivery System Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Nano-based Drug Delivery System Market Share by Application: 2024 VS 2031
Figure 10. Hydrophilic Drugs Case Studies
Figure 11. Hydrophobic Drugs Case Studies
Figure 12. Nano-based Drug Delivery System Report Years Considered
Figure 13. Global Nano-based Drug Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Nano-based Drug Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Nano-based Drug Delivery System Market Share by Region: 2024 VS 2031
Figure 16. Global Nano-based Drug Delivery System Market Share by Players in 2024
Figure 17. Global Top Nano-based Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano-based Drug Delivery System as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Nano-based Drug Delivery System Revenue in 2024
Figure 19. North America Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Nano-based Drug Delivery System Market Share by Country (2020-2031)
Figure 21. United States Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Nano-based Drug Delivery System Market Share by Country (2020-2031)
Figure 25. Germany Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Nano-based Drug Delivery System Market Share by Region (2020-2031)
Figure 33. China Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Nano-based Drug Delivery System Market Share by Country (2020-2031)
Figure 41. Mexico Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Nano-based Drug Delivery System Market Share by Country (2020-2031)
Figure 45. Turkey Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Nano-based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Amgen Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 49. Teva Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 50. Roche Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 51. UCB (Union Chimique Belge) Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 52. Celgene Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 54. Gilead Sciences Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 55. Sanofi Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 56. Pfizer Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 57. Takeda Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 58. Bausch&Lomb Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 59. Samyang Biopharmaceuticals Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 60. Johnson & Johnson Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 61. TOLMAR Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 62. Astellas Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 63. AMAG Pharmaceuticals Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 64. AbbVie Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 65. Dr Reddy Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 66. AstraZeneca Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 67. Aspen Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 68. Acrotech Biopharma Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 69. TWi Pharmaceuticals Revenue Growth Rate in Nano-based Drug Delivery System Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies